Skip to main content Skip to section navigation Skip to footer
Avalon GloboCare Corp.
  • Home
  • About
    • Overview
    • Executive Team
    • Board of Directors
  • Core Platforms
  • Investors
    • Overview
    • News & Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Information
    • Overview
    • Executive Team
    • Contacts
    • FAQ
  • Financial Information
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Corporate Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Apr 29, 2025 8:00am EDT

Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement

Apr 15, 2025 8:00am EDT

Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir

Apr 10, 2025 8:00am EDT

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

Apr 01, 2025 9:00am EDT

Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series

Mar 10, 2025 8:00am EDT

Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement

Feb 18, 2025 9:00am EST

Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China

Nov 21, 2024 9:00am EST

Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements

Nov 18, 2024 9:00am EST

Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device

Oct 31, 2024 9:00am EDT

Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales

Oct 25, 2024 9:00am EDT

Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 13
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
©2025 Avalon GloboCare Corp. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences